Efficacy and outcomes of inclisiran in the management of homozygous and heterozygous familial hypercholesterolemia: a systematic review and meta-analysis
Zaraq Khan(Indiana University), Aymar Akilimali(Roslin Institute), Hamza Islam(Punjab Medical College), Muhammad Yafaa Naveed Chaudhary(Indiana University), Aqeel Muhammad(Dow University of Health Sciences), Calvin R. Wei(Unknown), Raveena Devi(Isra University), Wajeeh Ur Rehman(Khyber Medical University), Monazza Riaz(Norfolk and Suffolk NHS Foundation Trust), Nimra Qasim, Ajeet Singh(Dow University of Health Sciences), Muhammad Rasool(Icahn School of Medicine at Mount Sinai), Farheen Naaz(Deccan College of Medical Sciences), Saif Syed(Royal College of Surgeons in Ireland), Rabia Islam(Sakarya University)
Cited by 2
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29
Barriers Encountered Toward Pursuing a Neurosurgical Career: A Cross-Sectional Study Among Medical Students, Interns, and Junior Doctors in Africa
|World Neurosurgery|2022|26
The unmet need of organ transplantation in Africa
|International Journal of Surgery|2023|21